Related Experiment Video
Updated: Aug 9, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Delaying and preventing type 2 diabetes mellitus]
1Vorsitzender des deutschen Dachverbandes Endokrinologie/Diabetologie.
Abstract:
In recent years, numerous studies have been concerned with delaying the manifestation of, or preventing, type 2 diabetes. In this connection, changes in lifestyle (weight reduction, physical activity) have proved to be particularly successful. Good results have, however, also been obtained with oral antidiabetics and/or ramipril. A striking finding has been the positive impact of acarbose on parameters of macroangiopathy.
Insights
Preventing type 2 diabetes is achievable through lifestyle changes like weight reduction and physical activity. Medications such as oral antidiabetics, ramipril, and acarbose also show promise, with acarbose notably improving macroangiopathy.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cardiovascular Health
Context:
- Type 2 diabetes prevention is a significant public health concern.
- Lifestyle interventions (weight reduction, physical activity) are established methods for diabetes management.
- Pharmacological interventions are also explored for diabetes prevention and management.
Purpose:
- To review current strategies for delaying or preventing type 2 diabetes.
- To highlight the efficacy of lifestyle modifications and pharmacological agents.
- To report on the specific benefits of acarbose on macroangiopathy.
Summary:
- Lifestyle changes, including weight reduction and increased physical activity, are highly effective in preventing type 2 diabetes.
- Oral antidiabetics and ramipril have demonstrated positive outcomes in diabetes management.
- Acarbose has shown a significant positive impact on macroangiopathy parameters.
Impact:
- Provides an overview of effective type 2 diabetes prevention strategies.
- Emphasizes the dual role of lifestyle and medication in managing diabetes.
- Highlights acarbose as a potential therapeutic agent for mitigating macrovascular complications in diabetes.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis